You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
普洛藥業(000739.SZ):擬出資3000萬元參設醫療創投基金
格隆匯 06-23 16:38

格隆匯6月23日丨普洛藥業(000739.SZ)公佈,公司於2022年6月22日與青島德豐傑龍脈投資中心(有限合夥)、青島市引導基金投資有限公司、青島市科技創新基金合夥企業(有限合夥)、海南德鼎創新投資有限公司、青島海泰新光科技股份有限公司、青島高新股權投資引導基金合夥企(有限合夥)共同簽署了《青島德豐傑龍脈醫療創業投資基金(有限合夥)(籌)合夥協議》。

公司將作為該合夥企業的有限合夥人(LP)以其自有資金認繳出資3000萬元與其他6家企業共同發起設立青島德豐傑龍脈醫療創業投資基金(有限合夥)(簡稱“創業投資基金”)。該創業投資基金的所有合夥人擬認繳出資總額為3億元。該基金聚焦硬科技、對標科創板,投資於戰略性新興領域,重點投資於醫療大數據和人工智能醫療、高技術醫療器械、創新藥等醫療領域的目標公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account